Motesanib with or without panitumumab plus FOLFIRI or FOLFOX for the treatment of metastatic colorectal cancer
Crossref DOI link: https://doi.org/10.1007/s00280-015-2694-y
Published Online: 2015-03-15
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tebbutt, Niall
Kotasek, Dusan
Burris, Howard A.
Schwartzberg, Lee S.
Hurwitz, Herbert
Stephenson, Joe
Warner, Douglas J.
Chen, Lisa
Hsu, Cheng-Pang
Goldstein, David
Text and Data Mining valid from 2015-03-15